Arena Pharmaceuticals Stock Went Up By Over 2% So Far On Friday

Shares of Arena Pharmaceuticals rose 2.71% to $67.08 at 13:05 EST on Friday, after two successive sessions in a row of losses. The Nasdaq Stock Market is jumping 0.59% to $12,450.00, following yesterday's upward trend, on what up until now seems, a somewhat positive trend exchanging session today. Arena Pharmaceuticals's last close was $65.31, 34.45% under its 52-week high of $90.19.

Arena Pharmaceuticals's Sales

Arena Pharmaceuticals's sales growth is a negative 81.3% for the present quarter and 155.7% for the next. The company's growth estimates for the ongoing quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals's Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.

Arena Pharmaceuticals's Stock Top and Bottom Yearly Value

Arena Pharmaceuticals's stock is valued at $67.08 at 13:05 EST, way below its 52-week high of $90.19 and way above its 52-week low of $32.95.

Arena Pharmaceuticals's Moving Average

Arena Pharmaceuticals's value is way below its 50-day moving average of $74.74 and below its 200-day moving average of $68.54.